Weave Bio
PrivateLast Round
Series A
Oct 16, 2025
Total Funding Raised
$36M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Weave Bio is a digital health company that provides an AI-native regulatory automation platform to streamline document preparation and lifecycle management for pharmaceutical and biotech companies.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Data Integration, Workflow Automation, RegTech, Biotechnology
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Weave Bio Comparables
Compare Weave Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hill Research | 83% | |
| Artos | 83% | |
| AlphaLife Sciences | 81% |
Weave Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 16, 2025 | ||||
| Seed | May 30, 2024 | ||||
| Pre Seed | Aug 7, 2022 |
Key People
Founding team and executive leadership
Weave Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Magnetic Ventures | Series A, Pre Seed, Seed |
| Innovation Endeavors | Series A, Pre Seed, Seed |
| Magnetic Ventures | Series A, Seed |
| Character Capital | Series A |
| U.S. Venture Partners | Series A |
| TMV | Series A |
| Serrado Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 4, 2026
Messaging infrastructure processes hundreds of millions of messages.
- Apr 4, 2026
Platform processes billions in annual payment volume.
Recent news
Latest coverage and updates
- integrates_withSep 2, 2026
Weave integrates with Takeda Pharmaceutical Co..
Weave Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Weave Bio's valuation, stock price, and market status.
Is Weave Bio a public or private company?
Weave Bio is a private company.
What is the current stock price of Weave Bio?
Weave Bio is a private company with no public stock price. Caplight tracks Weave Bio's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Weave Bio worth (valuation)?
Valuation information for Weave Bio is not publicly available.
Can I buy Weave Bio stock?
Weave Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Weave Bio's last funding round?
Weave Bio's most recent funding round was Series A on October 16, 2025.
Who are the main investors in Weave Bio?
Key investors in Weave Bio include Magnetic Ventures, Innovation Endeavors, Magnetic Ventures, U.S. Venture Partners.
Will Weave Bio IPO soon?
No public IPO plans have been announced for Weave Bio.
How can I track Weave Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Weave Bio's secondary market activity and sign up for updates.